Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early-morning Plasma Melatonin Levels Predict Cardiovascular Mortality After Acute Myocardial Infarction

NCT03230630 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT03230630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03230630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early-morning Plasma Melatonin Levels Predict Cardiovascular Mortality After Acute Myocardial Infarction
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2013
Completion date
January 1, 2017
Enrollment
732 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

melatonin, myocardial infarction